These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
581 related articles for article (PubMed ID: 24769842)
1. Decreased expression of NKG2D, NKp46, DNAM-1 receptors, and intracellular perforin and STAT-1 effector molecules in NK cells and their dim and bright subsets in metastatic melanoma patients. Mirjačić Martinović KM; Babović NLj; Džodić RR; Jurišić VB; Tanić NT; Konjević GM Melanoma Res; 2014 Aug; 24(4):295-304. PubMed ID: 24769842 [TBL] [Abstract][Full Text] [Related]
2. Favorable in vitro effects of combined IL-12 and IL-18 treatment on NK cell cytotoxicity and CD25 receptor expression in metastatic melanoma patients. Mirjačić Martinović K; Babović N; Džodić R; Jurišić V; Matković S; Konjević G J Transl Med; 2015 Apr; 13():120. PubMed ID: 25889680 [TBL] [Abstract][Full Text] [Related]
3. The stage dependent changes in NK cell activity and the expression of activating and inhibitory NK cell receptors in melanoma patients. Mirjačić Martinović K; Konjević G; Babović N; Inić M J Surg Res; 2011 Dec; 171(2):637-49. PubMed ID: 20828749 [TBL] [Abstract][Full Text] [Related]
4. Biomarkers of suppressed natural killer (NK) cell function in metastatic melanoma: decreased NKG2D and increased CD158a receptors on CD3-CD16+ NK cells. Konjević G; Mirjacić Martinović K; Jurisić V; Babović N; Spuzić I Biomarkers; 2009 Jun; 14(4):258-70. PubMed ID: 19489688 [TBL] [Abstract][Full Text] [Related]
5. Distribution of several activating and inhibitory receptors on CD3(-)CD56(+) NK cells in regional lymph nodes of melanoma patients. Vuletić A; Jurišić V; Jovanić I; Milovanović Z; Nikolić S; Konjević G J Surg Res; 2013 Aug; 183(2):860-8. PubMed ID: 23522458 [TBL] [Abstract][Full Text] [Related]
6. The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells. El-Sherbiny YM; Meade JL; Holmes TD; McGonagle D; Mackie SL; Morgan AW; Cook G; Feyler S; Richards SJ; Davies FE; Morgan GJ; Cook GP Cancer Res; 2007 Sep; 67(18):8444-9. PubMed ID: 17875681 [TBL] [Abstract][Full Text] [Related]
7. In vitro increased natural killer cell activity of metastatic melanoma patients with interferon-α alone as opposed to its combination with 13-cis retinoic acid is associated with modulation of NKG2D and CD161 activating receptor expression. Konjevic G; Mirjacic-Martinovic K; Vuletic A; Babovic N J BUON; 2012; 17(4):761-9. PubMed ID: 23335538 [TBL] [Abstract][Full Text] [Related]
8. In-vitro IL-2 or IFN-α-induced NKG2D and CD161 NK cell receptor expression indicates novel aspects of NK cell activation in metastatic melanoma patients. Konjević G; Mirjačić Martinović K; Vuletić A; Babović N Melanoma Res; 2010 Dec; 20(6):459-67. PubMed ID: 20938360 [TBL] [Abstract][Full Text] [Related]
9. Expansion of functionally skewed CD56-negative NK cells in chronic hepatitis C virus infection: correlation with outcome of pegylated IFN-alpha and ribavirin treatment. Gonzalez VD; Falconer K; Björkström NK; Blom KG; Weiland O; Ljunggren HG; Alaeus A; Sandberg JK J Immunol; 2009 Nov; 183(10):6612-8. PubMed ID: 19846870 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of CD158 and NKG2A Inhibitory Receptors and Underexpression of NKG2D and NKp46 Activating Receptors on NK Cells in Acute Myeloid Leukemia. Sandoval-Borrego D; Moreno-Lafont MC; Vazquez-Sanchez EA; Gutierrez-Hoya A; López-Santiago R; Montiel-Cervantes LA; Ramírez-Saldaña M; Vela-Ojeda J Arch Med Res; 2016 Jan; 47(1):55-64. PubMed ID: 26876298 [TBL] [Abstract][Full Text] [Related]
12. [Percentages and functions of natural killer cell subsets in peripheral blood of patients with severe aplastic anemia]. Li ZS; Shao ZH; Fu R; Wang J; Li LJ; Zhang T; Wang HQ; Wu YH; Ruan EB; Song J; Qu W; Liu H; Xing LM; Wang XM; Liang Y; Guan J; Wang GJ Zhonghua Yi Xue Za Zhi; 2011 Apr; 91(16):1084-7. PubMed ID: 21609587 [TBL] [Abstract][Full Text] [Related]
13. NKp46 and NKG2D receptor expression in NK cells with CD56dim and CD56bright phenotype: regulation by histamine and reactive oxygen species. Romero AI; Thorén FB; Brune M; Hellstrand K Br J Haematol; 2006 Jan; 132(1):91-8. PubMed ID: 16371024 [TBL] [Abstract][Full Text] [Related]
14. Expressions of natural cytotoxicity receptors and NKG2D on decidual natural killer cells in patients having spontaneous abortions. Zhang Y; Zhao A; Wang X; Shi G; Jin H; Lin Q Fertil Steril; 2008 Nov; 90(5):1931-7. PubMed ID: 18023431 [TBL] [Abstract][Full Text] [Related]
15. In-vitro activation of natural killer cells from regional lymph nodes of melanoma patients with interleukin-2 and interleukin-15. Vuletić AM; Jovanić IP; Jurišić VB; Milovanović ZM; Nikolić SS; Tanić NT; Konjević GM Melanoma Res; 2015 Feb; 25(1):22-34. PubMed ID: 25380182 [TBL] [Abstract][Full Text] [Related]
16. Decreased expression of pSTAT, IRF-1 and DAP10 signalling molecules in peripheral blood lymphocytes of patients with metastatic melanoma. Mirjačić Martinović K; Srdić-Rajić T; Babović N; Džodić R; Jurišić V; Konjević G J Clin Pathol; 2016 Apr; 69(4):300-6. PubMed ID: 26442832 [TBL] [Abstract][Full Text] [Related]
17. Abnormalities of quantities and functions of natural killer cells in severe aplastic anemia. Liu C; Li Z; Sheng W; Fu R; Li L; Zhang T; Wu Y; Xing L; Song J; Wang H; Shao Z Immunol Invest; 2014; 43(5):491-503. PubMed ID: 24661133 [TBL] [Abstract][Full Text] [Related]
18. Natural killer cell subsets and receptor expression in peripheral blood mononuclear cells of a healthy Korean population: Reference range, influence of age and sex, and correlation between NK cell receptors and cytotoxicity. Phan MT; Chun S; Kim SH; Ali AK; Lee SH; Kim S; Kim SH; Cho D Hum Immunol; 2017 Feb; 78(2):103-112. PubMed ID: 27884732 [TBL] [Abstract][Full Text] [Related]
19. Increased natural killer cell subsets with inhibitory cytokines and inhibitory surface receptors in patients with recurrent miscarriage and decreased or normal subsets in kidney transplant recipients late post-transplant. Zhu L; Aly M; Wang H; Karakizlis H; Weimer R; Morath C; Kuon RJ; Toth B; Ekpoom N; Opelz G; Daniel V Clin Exp Immunol; 2018 Aug; 193(2):241-254. PubMed ID: 29679490 [TBL] [Abstract][Full Text] [Related]
20. NK cells from malignant pleural effusions are not anergic but produce cytokines and display strong antitumor activity on short-term IL-2 activation. Vacca P; Martini S; Garelli V; Passalacqua G; Moretta L; Mingari MC Eur J Immunol; 2013 Feb; 43(2):550-61. PubMed ID: 23192659 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]